Home  >  Products  >  CDR2L (cerebellar degeneration-related protein 2-like) Blocking Peptide (the N terminal of CDR2L)(100ug)
CDR2L (cerebellar degeneration-related protein 2-like) Blocking Peptide (the N terminal of CDR2L)(100ug)

CDR2L (cerebellar degeneration-related protein 2-like) Blocking Peptide (the N terminal of CDR2L)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-CDR2L Antibody(ARP39113_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP39113
Size: 100ug
Weight: 53kDa
Gene: 30850
Format: Lyophilized powder
Target: The function of CDR2L remains unknown.
Alternative names: HUMPPA
See Full Product Listings >